Pharmacokinetics of the anti-human immunodeficiency virus nucleoside analog stavudine in cynomolgus monkeys

Antimicrob Agents Chemother. 1993 May;37(5):1160-2. doi: 10.1128/AAC.37.5.1160.

Abstract

Stavudine was administered (15 mg/kg of body weight) intravenously and orally to two monkeys in a randomized crossover study. Plasma and urine samples were analyzed for stavudine by high-performance liquid chromatography, and pharmacokinetic parameters were derived by a noncompartmental method. Total body clearance of stavudine was 0.64 liters/h/kg, with a steady-state volume of distribution of 0.68 liters/kg, a terminal half-life of 0.83 h, a urinary recovery of 44%, and an oral bioavailability of 80%. These values were reasonably similar to those reported for patients with AIDS or AIDS-related complex.

MeSH terms

  • Administration, Oral
  • Animals
  • Antiviral Agents / pharmacokinetics*
  • Biological Availability
  • Dideoxynucleosides / pharmacokinetics*
  • HIV / drug effects*
  • Half-Life
  • Humans
  • Macaca fascicularis
  • Male
  • Random Allocation
  • Stavudine

Substances

  • Antiviral Agents
  • Dideoxynucleosides
  • Stavudine